Amlodipine Besylate
Product Images NDC 71093-147

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71093-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aci Healthcare Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalsrtucture (Chemicalsrtucture)

Chemical structure of amlodipine besylate, showing the molecular arrangement of atoms and bonds typical for this compound, accompanied by its molecular formula C20H25ClN2O5S below the diagram.*

FDA Label Image

Container10mg1000cc (Container10mg1000cc)

Amlodipine Besylate Tablets, USP 10 mg package label showing a green and white design with a red circle indicating the 10 mg strength. The label states the package contains 1,000 tablets and includes storage instructions. The labeler is ACI Healthcare USA, Inc., and the manufacturer is Vimmed Life Sciences Private Limited in India.*

FDA Label Image

Container2.5mg500cc (Container2.5mg500cc)

Label for Amlodipine Besylate Tablets, USP, 2.5 mg strength, manufactured by Vivimed Life Sciences Private Limited and distributed by ACI Healthcare USA, Inc. The label states it contains 500 tablets, an NDC number 71093-146-05, and storage instructions with a barcode present.*

FDA Label Image

Container5mg1000cc (Container5mg1000cc)

Amlodipine Besylate Tablets USP, 5 mg, packaging label by ACI Healthcare USA, Inc. The label displays dosage strength (5 mg), quantity (1000 tablets), storage instructions, and directions for dispensing in light-resistant containers. The label includes manufacturer information, barcode, and a pharmacist instruction to dispense with patient information leaflet.*

FDA Label Image

Figure01 (Figure01)

A Kaplan-Meier plot showing event rates over 24 months comparing Amlodipine and Placebo groups. The graph includes hazard ratio, confidence interval, and p-value, with event rates on the y-axis and time in months on the x-axis, indicating cumulative events in each group over time.*

FDA Label Image

Figure02 (Figure02)

A forest plot chart showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across various patient subgroups including overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI-stent strata. The horizontal axis represents hazard ratio values from 0.0 to 2.0, with markers and confidence intervals indicating relative risk favoring either Amlodipine or placebo.*

FDA Label Image

Imprintingcode1 (Imprintingcode1)

Chemical structure diagram of amlodipine besylate, showing the molecular arrangement of this active ingredient.*

FDA Label Image

Imprintingcode2 (Imprintingcode2)

Chemical structure of Amlodipine Besylate, showing the molecular arrangement typical for this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.